In conclusion, the present study indicates that, although the cumulative risks at age 70 years of LS related cancer in MLH1, MSH2 and MSH6 mutation carriers are similar, each mutated gene has a distinguishable cancer risk profile. This evidence concerns the gene MLH1 and cancer.